Related Experiment Video

Updated: Jan 5, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.1K

Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations

Ming Li1, Cheng Zhan1

  • 1Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Annals of Translational Medicine
|October 29, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.6K

Related Experiment Videos

Last Updated: Jan 5, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.1K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

Articles linked to this work by shared authors, journal, and citation graph.

ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026

Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung Adenocarcinoma.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Cytokines and cancer-associated fibroblasts.

Journal of hematology & oncology·2026

Kidney neural diversity and blood pressure regulation: resolving controversies and guiding hypertension therapy.

Kidney international·2026

Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.

Cell death & disease·2026

A spin-crossover-mediated potential-dependent selective NO reduction reaction on iron-polyphthalocyanine: a DFT study.

Physical chemistry chemical physics : PCCP·2026

Tutorial: translating a validated breast cancer prediction model into a web-based decision aid using R Shiny.

Annals of translational medicine·2026

Erratum: Electroacupuncture attenuates spared nerve injury-induced neuropathic pain possibly by promoting the progression of AMPK/mTOR-mediated autophagy in spinal microglia.

Annals of translational medicine·2026

Beyond the algorithm: health technology assessment frameworks for AI in cardiology under the European Union Health Technology Assessment Regulation: a systematic review.

Annals of translational medicine·2026

Bronchoscopic photodynamic therapy for endobronchial metastatic papillary thyroid carcinoma causing lobar airway obstruction: a case report.

Annals of translational medicine·2026

Light therapy in medicine: where do we stand?

Annals of translational medicine·2026

Clonal hematopoiesis of indeterminate potential (CHIP)-a pivotal contributor of aging and related disorders.

Annals of translational medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us